Takatoshi Enomoto

4PUBLICATIONS
2CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 28, 2022
COVID-19 in a human T-cell lymphotropic virus type-1 carrier.

Takatoshi Enomoto, Takayuki Shiroyama, Haruhiko Hirata

|Feb 22, 2022
Correction to: Nivolumab treatment beyond progressive disease in advanced non‑small cell lung cancer.

Takatoshi Enomoto, Akihiro Tamiya, Kinnosuke Matsumoto

|Jul 15, 2020
Nivolumab treatment beyond progressive disease in advanced non-small cell lung cancer.

Takatoshi Enomoto, Akihiro Tamiya, Kinnosuke Matsumoto

|Feb 20, 2020
Efficacy and tolerance of immune checkpoint inhibitors for non-small cell lung cancer patients with interstitial lung disease.

Kinnosuke Matsumoto, Yuichi Adachi, Takatoshi Enomoto

Pageof 1